Immune function and recovery — what the evidence shows

Most people who reach this page have already been somewhere else first. A doctor, often several. Tests that came back normal. An explanation that didn’t explain much.

That is a specific kind of tired, and it makes people vulnerable to anyone offering a clean answer.

This page is not going to offer one. What it can offer is a physician who will look at your case and tell you honestly whether there is anything worth discussing — and who is willing to say there isn’t.

	Continue with your current doctors	Continue and request a review here	Treat it yourself with supplements or wellness protocols	Wait
What it is	Keep working with the physicians already investigating	Your current care continues; a physician separately reviews whether an immunological approach is worth discussing	Self-directed products marketed for “immune support”	Do nothing now; revisit if things change
Who tends to consider it	Everyone, and it should stay in place	People whose work-up hasn’t explained the problem, or whose recovery has stalled	People who feel they’re out of options	People whose symptoms fluctuate
What the evidence says	This is where diagnosis happens, and diagnosis is what most of these situations need	Evidence for specific interventions is limited, and for some conditions absent — stated by condition in section 4	Largely unevaluated. Marketed heavily, studied little	Depends entirely on what is causing it
Certainty	High	Low	High that it’s unevaluated	Not applicable

Column two is honest about its own weakness. The evaluation may be worthwhile even where the evidence for a particular intervention is not established — those are two different things, and this page keeps them separate throughout.

What this is. This route is about an evaluation rather than a treatment, and that is not a formality — it follows from what the products in this space actually claim to do.

What they are trying to do. Almost every immune medicine in ordinary use works by turning the immune system down: steroids, immunosuppressants, biologics for autoimmune disease. The products discussed here claim the opposite direction — supporting a system that is doing too little rather than too much. Transfer factor, thymic peptides and similar products rest on the idea that immune signalling can be nudged upward.

Why researchers became interested. Because that direction is genuinely underexplored, and because one product shows the idea is not absurd: thymalfasin, a defined synthetic peptide, is an approved prescription medicine in more than 30 countries.

And the same fact explains why the evidence here is thin. There is far less precedent to build on than in immune suppression, and much of what exists comes from the manufacturers themselves.

Why someone might reasonably discuss it with a physician. Because “my immune system isn’t working” describes dozens of different problems, and which one a person actually has changes the answer completely.

This is the section where this route differs most from the others, so it is worth saying plainly what you are about to read.

Every claim below has its trials, its sources, its funding and its regulatory history in The evidence, audited — one click down, kept separate so this section stays readable, not to keep it out of your way.

For most of these conditions, we do not have trial evidence to show you — and where evidence exists, it is usually about something adjacent rather than about the problem you have.

Find the one that describes you. You do not need to read the others.

It doesn’t show that these interventions work for these problems. The most honest summary of this route’s therapeutic evidence is: thin where it exists, absent where it doesn’t.

And where it does exist, it has gone both ways. A cell therapy approved in the European Union in 2018 had its authorisation withdrawn in December 2024, after a larger confirmatory trial found the placebo group did just as well. A small positive trial is not a conclusion. The trial.

It doesn’t show that a promising signal survives a proper trial. The best- studied thymic peptide looked effective across many small studies. When the analysis was restricted to the larger, higher-quality, multi-centre trials, the benefit disappeared — and the largest rigorous trial found no difference at all. The impressive number was the sum of the weak studies. The pooled analysis and the trial that replaced it.

It doesn’t show that “immune support” is a treatable target. The wellness industry sells to exactly the people who reach this page. There is no test that scores your immune system and no product shown to raise the score.

Approval is applied for, granted per country and per indication.

→ The full explanation, including what actually protects you →

Whether an evaluation is worth it on its own. You may come out of this with an explanation and no treatment. For some people that is worth the trip; for others it isn’t. Both are reasonable.

How you weigh an honest “we don’t know.” This route says it more than the others, because it is more often true here.

What you have already spent. People in this situation have often paid for several rounds of tests and several rounds of products. That history is worth counting before adding to it.

You believe you have a “weak immune system” and want it strengthened. That is not a diagnosis, and this route will not treat it as one. If a provider offers to fix it, that is the moment to leave.

• Nobody has investigated your symptoms yet. Every situation on this page assumes a medical evaluation already happened. If it hasn’t, that is the step you need — not this one. - You are looking for a list of qualifying diagnoses. Some autoimmune conditions may be appropriate for review and others may not: it depends on the diagnosis, how active the disease is, what treatment you are on, and your overall condition. We don’t publish a list, because a list would tell you that you qualify when only an evaluation can. - You have an active infection or an urgent medical problem. That needs conventional care now. - You need certainty that a treatment will help. On this route, more than the others, we cannot offer that. - You’re not willing to share your medical records. A responsible review cannot be carried out without them. - You want to stop or replace treatment you’re already on. No legitimate provider will suggest that.

1. What would an evaluation actually tell me that my current doctors haven’t?
2. What published evidence exists for this intervention in my situation — not in general?
3. Where was this product made, and under what registration?
4. What testing is done on each batch before release?
5. What would make you tell me I’m not a candidate?
6. If I’m recovering from cancer treatment: could anything you’re proposing interfere with treatment I might still need?
7. What happens if it doesn’t work?

Print this list.

About half of health searches are made for another person, and this route has more of them than most: people in this situation are often exhausted.

Print sections 4 and 8. Section 4 is the honest inventory of what is and isn’t known. Section 8 is how to tell if this isn’t the right door.

You can begin a review on their behalf — but before any medical record is shared or the clinical review continues, the patient must consent.

1. You send records through a secure upload link. What the physician needs for this review lists exactly what to gather.
2. An independent physician reviews the case. Some patients are advised that this treatment is not appropriate for their situation.
3. If they consider it appropriate, they speak with you directly and explain any applicable fees at that point. Human Paths does not set, publish, collect or process payment for healthcare services.
4. You decide.

The treating physician confirms the final schedule after reviewing your case.

The request form is linked from the home page, deliberately not from here: reading the evidence and asking for a review are two separate steps.